Alterity Therapeutics Limited submitted its May 2026 Corporate Presentation as Exhibit 99.1 in a Form 6-K filing, incorporating it by reference into multiple registration statements.
Key takeaways
Filed Form 6-K for the month of May 2026.
Attached Exhibit 99.1: Corporate Presentation May 2026.
Incorporated into Form S-8 (333-251073, 333-248980, 333-228671) and Form F-3 (333-274816, 333-251647, 333-231417, 333-250076) registration statements.
Signed by Chairman Julian Babarczy on May 12, 2026.
Company described as a development stage enterprise.